Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,105,671 articles, preprints and more)

Suggested authors matching "AUTH:von Bubnoff N" with an ORCID

Nikolas von Bubnoff von Bubnoff
No affiliation detected
7
Publications
382
Citations
View profile

Search results

1-25 of 172 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the ECNM
Rüfer A, Nilius H, Hermine O, Niedoszytko M, Elberink HO, Bonadonna P, Shoumariyeh K, Gulen T, Hartmann K, Sabato V, Angelova-Fischer I, Baffoe D, Fortina AB, Breynaert C, Brockow K, von Bubnoff N, Bumbea H, Daele Pv, Doubek M, [...] Valent P
Research Square, 03 Sep 2024
Cited by: 0 articles | PPR: PPR905501
Add to export list Preprint v1
Case report: Tenosynovial giant cell tumor.
Fähnrich A, Gasimova Z, Maluje Y, Ott F, Sievert H, Fliedner S, Reimer N, Künstner A, Gebauer N, Kebenko M, von Bubnoff N, Kirfel J, Sailer VW, Röcken C, Konukiewitz B, Klapper W, Frydrychowicz A, Mogadas S, Huebner G, [...] Khandanpour C
Front Oncol, 14:1445427, 26 Sep 2024
Cited by: 0 articles | PMID: 39391235 | PMCID: PMC11464255
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasms.
Kaehler M, von Bubnoff N, Cascorbi I, Gorantla SP
Front Pharmacol, 15:1422565, 22 Jul 2024
Cited by: 0 articles | PMID: 39104388 | PMCID: PMC11298451
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Development, Involvement and Use of an Overarching In-House Registry for Clinical Trials.
Ablaß T, Simon F, Schwitlick C, Olbrich D, Brandt K, Hohensee I, von Bubnoff N, Baldus C, Ingenerf J, Schreiweis B, Kock-Schoppenhauer AK
Stud Health Technol Inform, 317:123-128, 01 Aug 2024
Cited by: 0 articles | PMID: 39234714
Add to export list
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.
Kuehn JC, Metzger P, Neidert N, Matysiak U, Gräßel L, Philipp U, Bleul S, Pauli T, Falkenstein J, Bertemes H, Cysar S, Hess ME, Frey AV, Duque-Afonso J, Schorb E, Machein M, Beck J, Schnell O, von Bubnoff N, [...] Scherer F
NPJ Precis Oncol, 8(1):180, 14 Aug 2024
Cited by: 0 articles | PMID: 39143272 | PMCID: PMC11324882
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms.
Gorantla SP, Prince G, Osius J, Dinesh DC, Boddu V, Duyster J, von Bubnoff N
Front Oncol, 14:1430833, 18 Jul 2024
Cited by: 0 articles | PMID: 39091915 | PMCID: PMC11291247
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged organ-tropism
Künstner A, von Kopylow V, Lohneis P, Kümmel M, Witte HM, Bastian L, Bernard V, Stölting S, Kusch K, Krokowski M, von Bubnoff N, Steinestel K, Arndt A, Merz H, Busch H, Feller AC, Gebauer N
medRxiv, 17 Jul 2024
Cited by: 0 articles | PPR: PPR883036
Add to export list Preprint
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma.
Arndt A, Neumann C, Riecke A, Bauer A, Müller M, Wölfle-Guter M, Grunert M, Busch H, Künstner A, von Bubnoff N, Fliedner S, Greinert D, Osius J, Nagarathinam K, Steinestel K, Gorantla SP, Gebauer N, Witte HM
Oncologist, oyae143, 03 Jul 2024
Cited by: 0 articles | PMID: 38960389
Add to export list
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN).
Isfort S, von Bubnoff N, Al-Ali HK, Becker H, Götze T, le Coutre P, Griesshammer M, Moskwa C, Wohn L, Riedel J, Palandri F, Manz K, Hochhaus A, Döhner K, Heidel FH
Ann Hematol, 103(8):2775-2785, 05 Jul 2024
Cited by: 1 article | PMID: 38967662
Add to export list
Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone.
Denker S, Künstner A, Schwarting J, Witte HM, Bernard V, Stölting S, Lohneis P, Kusch K, von Bubnoff N, Merz H, Busch H, Feller AC, Gebauer N
Leukemia, 38(8):1858-1861, 18 Jun 2024
Cited by: 0 articles | PMID: 38890446 | PMCID: PMC11286505
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
Lübke J, Schmid A, Christen D, Oude Elberink HNG, Span LFR, Niedoszytko M, Gorska A, Lange M, Gleixner KV, Hadzijusufovic E, Stefan A, Angelova-Fischer I, Zanotti R, Bonifacio M, Bonadonna P, Shoumariyeh K, von Bubnoff N, Müller S, Perkins C, [...] Schwaab J
Blood Adv, 8(11):2890-2900, 01 Jun 2024
Cited by: 1 article | PMID: 38593217
Add to export list
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, [...] ASC4FIRST Investigators
N Engl J Med, 391(10):885-898, 31 May 2024
Cited by: 3 articles | PMID: 38820078
Add to export list
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features.
Künstner A, Schwarting J, Witte HM, Xing P, Bernard V, Stölting S, Lohneis P, Janke F, Salehi M, Chen X, Kusch K, Sültmann H, Chteinberg E, Fischer A, Siebert R, von Bubnoff N, Merz H, Busch H, Feller AC, Gebauer N
Leukemia, 38(5):1086-1098, 10 Apr 2024
Cited by: 3 articles | PMID: 38600314 | PMCID: PMC11073989
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores.
Kappenstein M, von Bubnoff N
Cancers (Basel), 16(7):1416, 05 Apr 2024
Cited by: 0 articles | PMID: 38611094 | PMCID: PMC11011132
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C, de Andrade Krätzig N, Pecoraro M, Lange S, Seifert P, von Frankenberg C, Untch J, Zuleger G, Wilhelm M, Zolg DP, Dreyer FS, Bräunlein E, Engleitner T, Uhrig S, Boxberg M, Steiger K, Slotta-Huspenina J, Ochsenreither S, von Bubnoff N, [...] Krackhardt AM
Nat Commun, 15(1):2364, 15 Mar 2024
Cited by: 0 articles | PMID: 38491045 | PMCID: PMC10943035
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Clinical Features of Hereditary Alpha-Tryptasemia.
von Bubnoff D, Koch D, Stocker H, Ludwig RJ, Wortmann F, von Bubnoff N
Dtsch Arztebl Int, 121(8):258-264, 01 Apr 2024
Cited by: 0 articles | PMID: 38260947 | PMCID: PMC11381211
Add to export list Review Free full text in Europe PMC
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Boddu VK, Zamzow P, Kramer MW, Merseburger AS, Gorantla SP, Klinger M, Cramer L, Sauer T, Gemoll T, von Bubnoff N, Gieseler F, Darabi M
Cell Commun Signal, 22(1):129, 15 Feb 2024
Cited by: 1 article | PMID: 38360687 | PMCID: PMC10870545
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature.
von Fritsch L, von Bubnoff N, Weber K, Kirfel J, Schreiber C, Keck T, Wellner U
Genes Chromosomes Cancer, 63(2):e23222, 01 Feb 2024
Cited by: 1 article | PMID: 38340027
Add to export list Review
Type II JAK2 Inhibitor CHZ‐868 and HSP90 Inhibitors Are Potent towards the Ruxolitinib Resistant JAK2 Variants in JAK2 Driven Myeloproliferative Neoplasms
Gorantla SP, Prince G, Osius J, Dinesh D, Boddu VK, Duyster J, Von Bubnoff N
Preprints.org, 03 Jan 2024
Cited by: 0 articles | PPR: PPR782228
Add to export list Preprint v1
A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance.
Gorantla SP, Mueller TA, Albers-Leischner C, Rudelius M, von Bubnoff N, Duyster J
Mol Oncol, 18(2):415-430, 20 Dec 2023
Cited by: 2 articles | PMID: 38104968 | PMCID: PMC10850816
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.
Frank D, Patnana PK, Vorwerk J, Mao L, Gopal LM, Jung N, Hennig T, Ruhnke L, Frenz JM, Kuppusamy M, Autry R, Wei L, Sun K, Mohammed Ahmed HM, Künstner A, Busch H, Müller H, Hutter S, Hoermann G, [...] Khandanpour C
Blood, 142(25):2175-2191, 01 Dec 2023
Cited by: 1 article | PMID: 37756525 | PMCID: PMC10733838
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor-modulating factors.
Nording H, Baron L, Sauter M, Lübken A, Rawish E, Szepanowski R, von Esebeck J, Sun Y, Emami H, Meusel M, Saraei R, Schanze N, Gorantla SP, von Bubnoff N, Geisler T, von Hundelshausen P, Stellos K, Marquardt J, Sadik CD, [...] Langer HF
Blood Adv, 7(21):6411-6427, 01 Nov 2023
Cited by: 1 article | PMID: 37257194 | PMCID: PMC10598500
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Genome-wide DNA methylation-analysis delineates blastic plasmacytoid dendritic cell neoplasm from related entities and identifies distinct molecular features
Künstner A, Schwarting J, Witte HM, Xing P, Bernard V, Stölting S, Lohneis P, Janke F, Salehi M, Chen X, Kusch K, Sültmann H, Chteinberg E, Fischer A, Siebert R, von Bubnoff N, Merz H, Busch H, Feller AC, Gebauer N
medRxiv, 04 Aug 2023
Cited by: 0 articles | PPR: PPR703176
Add to export list Preprint
P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
Chary Nimmagadda S, Marie Budde P, Sun K, Covey T, Krejsa C, Rothbaum W, von Bubnoff N, Khandanpour C
Hemasphere, 7(suppl ), 01 Aug 2023
Cited by: 0 articles | PMCID: PMC10431568
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C, de Andrade Krätzig N, Pecoraro M, Lange S, Seifert P, von Frankenberg C, Untch J, Zuleger G, Wilhelm M, Zolg DP, Dreyer FS, Bräunlein E, Engleitner T, Uhrig S, Boxberg M, Steiger K, Slotta-Huspenina J, Ochsenreither S, von Bubnoff N, [...] Krackhardt AM
Nat Commun, 14(1):4632, 02 Aug 2023
Cited by: 10 articles | PMID: 37532709 | PMCID: PMC10397250
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 172 results

1 2 3 Next ...

Search life-sciences literature (45,105,671 articles, preprints and more)

Suggested authors matching "AUTH:von Bubnoff N" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:von Bubnoff N" with an ORCID